Structure-based synthesis: From natural products to drug prototypes

Pure and Applied Chemistry

Volumn 81, Issue 6, 2009, Pages 1085-1091

  Hanessian, Stephen ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Indolizidinone carboxylic acids; Linear peptides; Octahydroindole carboxylic acids; Thrombin inhibitors

Indexed keywords

EID: 67650739245     PISSN: 00334545     EISSN: 13653075     Source Type: Journal    
DOI: 10.1351/PAC-CON-08-07-12     Document Type: Conference Paper

References (63)

1. See, e.g.: (a) D. D. Baker, M. Chu, U. Oza, V. Rajgarhia. Nat. Prod. Rep. 24, 1225 (2007);
2. (b) M. S. Butler. Nat. Prod. Rep. 22, 162 (2005);
3. (c) V. P. Gullo (Ed.). The Discovery of Natural Products with Therapeutic Potential, Butterworth-Heinemann, Boston (1994).
4. See, e.g.: (a) K. C. Nicolaou, T. Montagnon. Molecules that Changed the World, Wiley-VCH, Weinheim (2008);
5. (b) E. J. Corey, B. Czakó, L. Kürti. Molecules and Medicine, John Wiley, New York (2007);
6. (c) K. C. Nicolaou, E. J. Sorensen. Classics in Total Synthesis II, Wiley-VCH, Weinheim (2003).
7. (a) W. Cabri, R. DiFabio. From Bench to Market-The Evolution of Chemical Synthesis, Oxford University Press, Oxford (2000);
8. (b) K. G. Gadamasetti (Ed.). Process Chemistry in the Pharmaceutical Industry, Dekker, New York (1999); for a recent thematic issue, see
9. (c): M. F. Lipton, A. G. M. Barrett (Guest Eds.). Chem. Rev. 106, 2581 (2006).
10. See, e.g., NMR: (a) S. B. Shuker, P. J. Hajduk, R. P. Meadows, S. W. Fesik. Science 274, 1531 (1996);
11. (b) J. Fejzo, C. A. Lepre, J. W. Peng, G. W. Bemis, Ajay, M. A. Murcko, J. M. Moore. Chem. Biol. 6, 755 (1999);
12. (c) M. Pellechia, D. S. Sem, K. Wüthrich. Nat. Rev. Drug Discov. 1, 211 (2002); X-ray: (d) V. L. Nienaber, P. L. Richardson, V. Klighofer, J. J. Bouska, V. L. Giranda, J. Greer. Nat. Biotechnol. 18, 1105 (2000); (e) A. Sharff, H. Jhoti. Curr. Opin. Chem. Biol. 7, 340 (2003); (f) L. Blundell, H. Jhoti, C. Abell. Nat. Rev. Drug Discov. 1, 45 (2002).
13. M. Gordaliza. Clin. Transl. Oncol. 9, 767 (2007).
14. For a recent review, see: (a) K. Ersmark, J. R. Del Valle, S. Hanessian. Angew. Chem., Int. Ed. 47, 1202 (2008); see also
15. (b) J. W. Blunt, B. R. Copp, W.-P. Hu, M. H. G. Munro, P. T. Northcote, M. R. Prinsep. Nat. Prod. Rep. 24, 31 (2007);
16. (c) A. M. Burja, B. Banaigs, E. Abou-Mansour, J. G. Burgess, P. C. Wright. Tetrahedron 57, 9347 (2001);
17. (d) W. J. Gerwick, L. T. Tan, N. Sitachitta. In Alkaloids: Chemistry and Biology, Vol. 57, p. 75, G. A. Cordell (Ed.), Academic Press, San Diego (2001);
18. (e) H. Luesch, G. G. Harrigan, G. Goetz, F. D. Horgen. Curr. Med. Chem. 9, 1791 (2002);
19. (f) M. Namikoshi, K. L. Rinehart. J. Int. Microbiol. 17, 373 (1996);
20. (g) R. Lukkainen, K. Sivonen, M. Manikoshi, M. Färdig, K. L. Rinehart, S. I. Nimelä. Appl. Environ. Microbiol. 59, 2204 (1993).
21. For total syntheses of aeruginosin 298A and 298B, see: (a) T. Ohshima, V. Gnanadesikan, T. Shibuguchi, Y. Fukuta, T. Nemoto, M. Shibasaki. J. Am. Chem. Soc. 125, 11206 (2003);
22. (b) N. Valls, M. López-Canet, M. Vallribera, J. Bonjoch. Chem.-Eur. J. 7, 3446 (2001);
23. (c) J.-L. Methot, P. Wipf. Org. Lett. 2, 4213 (2000);
24. (d) N. Valls, M. López-Canet, M. Vallribera, J. Bonjoch. J. Am. Chem. Soc. 122, 11248 (2000); see also
25. (e) J. L. Rios Teiner, M. Murakami, A. Tulinsky. J. Am. Chem. Soc. 120, 597 (1998).
26. See, e.g.: (a) E. W. Davie, J. D. Kulman. Semin. Thromb. Hemostasis 32, 3 (2006);
27. (b) B. Dahlbäck. J. Int. Med. Res. 257, 209 (2005);
28. (c) J. D. Kulman, E. W. Davie. Encycl. Biol. Chem. 3, 457 (2004);
29. (d) The World Health Organization (WHO) Cardiovascular Disease (CVD); Global Strategy on Diet, Physical Activity and Health,WHO (2003);
30. (e) E. W. Davie. J. Biol. Chem. 278, 50819 (2003);
31. (f) R. W. Colman, A. W. Clowes, J. N. George, J. L. Hirsch, J. V. Marder. In Overview of Homeostasis, 4th ed., R. W. Colman, J. L. Hirsh, J. V. Marder, A. W. Clowes, J. N. George (Eds.), p. 3, Lippincott Williams & Wilkins, Philadelphia (2001);
32. (g) J. J. Sidelmann, J. Gram, J. Jespersen, C. Kluft. Semin. Thromb. Hemostasis 26, 605 (2000).
33. (a) S. Hanessian, J. R. Del Valle, Y. Xue, N. Blomberg. J. Am. Chem. Soc. 128, 10491 (2006); see also
34. (b) G. H. Goetz, G. G. Harrigan, J. J. Likos, T. D. Kasten. WO 03/051831.
35. (a) S. Hanessian, R. Margarita, A. Hale, S. Johnstone, M. Tremblay, L. Parlanti. J. Am. Chem. Soc. 124, 13342 (2002);
36. (b) S. Hanessian, R. Margarita, A. Hall, S. Johnstone, M. Tremblay, L. Parlanti. Pure Appl. Chem. 75, 209 (2003); see also
37. (c) A. R. Caroll, G. Pierens, G. Fecher, G. P. de Almeida Leone, M. Simpson, J. N. Hooper, S.-L. Boström, D. Musil, R. J. Quinn. J. Am. Chem. Soc. 124, 13340 (2002);
38. (d) A. R. Carroll, M. S. Buchanan, A. Edser, E. Hyde, M. Simpson, R. J. Quinn. J. Nat. Prod. 67, 1291 (2004).
39. (a) S. Hanessian, M. Tremblay, J. F. W. Petersen. J. Am. Chem. Soc. 126, 6064 (2004); see also
40. (b) R. Engh, S. Konetschny-Rapp, H.-W. Krell, U. Martin. WO 96/11941;
41. (c) R. Engh, S. Konetschny-Rapp, H.-W. Krell, U. Martin, C. Tsaklakidis. WO 97/21725.
42. W. Bode, D. Turk, A. Karshikov. Protein Sci. 1, 426 (1992).
43. S. Hanessian, E. Balaux, D. Musil, L.-L. Olsson, I. Nilsson. Bioorg. Med. Chem. Lett. 10, 243 (2000).
44. (a) S. Hanessian, E. Therrien, K. Granberg, I. Nilsson. Bioorg. Med. Chem. Lett. 12, 2907 (2002); see also
45. (b) S. Hanessian, H. Sailes, A. Munro, E. Therrien. J. Org. Chem. 68, 7219 (2003).
46. S. Hanessian, H. Sailes, E. Therrien. Tetrahedron 59, 7047 (2003).
47. For selected examples of aeruginosin core analogs, see: (a) Z. Liu, J. D. Ranier. Org. Lett. 8, 459 (2006);
48. (b) X. Nie, G. Wang. J. Org. Chem. 70, 8687 (2005);
49. (c) Y. Fukuta, T. Ohshima, V. Gnanadesikan, T. Shibuguchi, T. Nemoto, T. Kisugi, T. Okino, M. Shibasaki. Proc. Natl. Acad. Sci. USA 101, 5433 (2004);
50. (d) N. Toyooka, M. Okumura, T. Himiyama, A. Nakazawa, H. Nemoto. Heterocycles 59, 75 (2003);
51. (e) N. Toyooka, M. Okumura, T. Himiyama, A. Nakazawa, H. Nemoto. Synlett 55 (2003);
52. (f) N. Valls, M. Vallribera, M. Font-Bardia, X. Solans, J. Bonjoch. Tetrahedron: Asymmetry 14, 1241 (2003);
53. (g) G. Radau, J. Stürzebecher. Pharmazie 57, 11 (2002);
54. (h) G. Radeau, D. Rauh. Bioorg. Med. Chem. Lett. 10, 779 (2000);
55. (i) J. Bonjoch, J. Catena, E. Isábal, M. López-Canet, N. Valls. Tetrahedron: Asymmetry 7, 1999 (1996);
56. (j) P. Wipf, Y. Kim. Tetrahedron Lett. 33, 5477 (1992); for a "library" approach, see
57. (k) T. Doi, Y. Hoshina, H. Mogi, Y. Yamada, T. Takahashi. J. Comb. Chem. 8, 571 (2006).
58. S. Hanessian, S. Guillemette, K. Ersmark. Chimia 61, 361 (2007).
59. S. Hanessian, K. Ersmark, J. Wang, J. R. Del Valle, N. Blomberg, Y. Xue, O. Fjellström. Bioorg. Med. Chem. Lett. 17, 3480 (2007).
60. S. Hanessian, E. Therrien, W. A. L. van Otterlo, M. Bayrakdarian, I. Nilsson, O. Fjellström, Y. Xue. Bioorg. Med. Chem. Lett. 16, 1032 (2006).
61. S. Hanessian, D. Simard, M. Bayrakdarian, E. Therrien, I. Nilsson, O. Fjellström. Bioorg. Med. Chem. Lett. 18, 1972 (2008).
62. K. Berggren, O. Davidsson, O. Fjellström, D. Gustafsson, S. Hanessian, T. Inghardt, M. Någård, I. Nilsson, E. Therrien, W. A. L. Van Otterlo. WO 2005/058826.
63. S. Hanessian. ChemMedChem 1, 1300 (2006).